Search

Diana Pires (University of Minho, Portugal) and colleagues published a new Scientific Reports paper describing the design and assembly of synthetic Pseudomonas aeruginosa phages made by knocking out up to 48% of a phage's genes of unknown f

Christine Thompson, a US pharmacy student keen to learn more about bringing phage therapy into the field of pharmacy, published an interview for IDStewardship.com with Phage Directory's co-founder, Jessica Sacher. They discussed recent phag

Tom Ireland, a freelance science journalist, has published a great article in BBC Science Focus called The best way to kill a superbug? Weaponise a virus. Throughout this article, Tom introduces phages, their history, and the importance of

As promised, the 24th biennial Evergreen International Phage Meeting will take place the first week of August 2021! Assuming it is safe to do so, the conference will be hosted in person on the Evergreen campus, in the dorms, as done in the

The sixth iVoM event will be Thursday, February 18, 11AM GMT (note time change!), and the theme will be "Biotechnology applications in health care". It will feature talks by: Laurent Debarbieux: Phages (in)action in the gut Krystyna Dabrows

Dear iVoM participants, If you've attended at least two iVoM events, you're invited to participate in a contest! The contest aims at having the audience feedback regarding the iVoM: Viruses of Microbes 2020 Webinar Series: Take a walk on th

This week, we're highlighting the four feature articles we published in January: Phage Directory's 2021 outlook, a guest blog post, an interview, and a first look at our State of Phage survey results! Enjoy! In this month's Capsid & Tail Mo

Phage biotech company Proteon Pharma (Warsaw, Poland) is hiring a business analyst.

Armata Pharmaceuticals (Marina del Rey, California) is hiring an Associate Scientist/Scientist Phage & Bacterial Genetics, Engineering & Synthetic Biology to evaluate existing engineering methods and devise new ones to build improved phages

In celebration of our 100th issue of Capsid & Tail, we launched a survey called State of Phage 2020! We created this survey to help us all better understand the phage research community globally, including what kind of phages people are col

This issue was sponsored by Kisaco Research for Phage Futures 2021.

PHAVES #12 will be a seminar with Dr. Betty Kutter of the Evergreen State College on Tues, Feb 9 at 8AM Pacific Time / 11AM Eastern Time. Title: Phages as a teaching tool, and stories from 60 years of phage. Small group networking to follow

PHAVES #12 will be a seminar with Dr. Betty Kutter of the Evergreen State College on Tues, Feb 9 at 8AM Pacific Time / 11AM Eastern Time. Title: Phages as a teaching tool, and stories from 60 years of phage. Small group networking to follow

Carmen (@PhageAnt on Twitter) would like to hear from you! Do you have any recommendations for any conferences/talks that are heavily involved in viral metagenomics? Reply to the Twitter post if you have any suggestions!

My name is Farhad Afrasiabi. Ph.D. student in the Department of Microbiology at Hamadan University of Medical Sciences, IRAN. I am interested in working on phage. I am currently working on a joint project to do my doctoral thesis on phage.

Armata Pharmaceuticals announced a $20 Million investment to support advancement of its clinical phage development programs. Armata aims to complete a phage clinical trial (Phase 1b/2a, P. aeruginosa) and initiate three more in 2021-2022.

Holger Buchholz (University of Exeter, UK) and colleagues published a new paper in The ISME Journal showing a high-throughput method for isolating virus-host model systems for fastidious heterotrophic bacteria. Using this method, 117 new ph

Janet Nale (University of Leicester, UK) and colleagues published a new paper in Frontiers in Microbiology on how an optimized phage cocktail they developed can effectively control Salmonella. They administered the three-phage cocktail to G

Jingen Zhu (The Catholic University of America, Washington, DC) and colleagues published a new preprint describing the use of CRISPR-engineered phage T4 as a universal platform to produce vaccines against SARS-CoV-2. They found high levels

Nitasha Menon (Amrita Vishwa Vidyapeetham University, India) and colleagues published a new paper in mSphere on a phage they isolated from sewage that has activity against multidrug resistant clinical isolates of Pseudomonas aeruginosa in S